Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| PS P2 ScienceCompany profile Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials | $23M | Undisclosed | Biotech, Climate tech | United States | Investors | |
| P PhytolonCompany profile Develops natural food colors using precision fermentation technology to replace synthetic dyes Develops natural food colors using precision fermentation technology to replace synthetic dyes | $23.6M | Series B | Biotech, Foodtech | Israel | Investors | |
| KD Kordata DynamicsCompany profile Provides AI-powered precision clinical trials platform using real-time neural biomarker data Provides AI-powered precision clinical trials platform using real-time neural biomarker data | Undisclosed | Pre-SeedPre-seed | Biotech, Healthtech | United States | Investors | |
| P PatinaCompany profile Discovers new scent molecules for fragrance and flavor industries using ML-based olfactory modeling Discovers new scent molecules for fragrance and flavor industries using ML-based olfactory modeling | $2M | Seed | Biotech | United States | Investors | |
| SC Synakis CorpCompany profile Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage | CA$2.6M | Pre-SeedPre-seed | Biotech | Canada | Investors | |
| I ImperagenCompany profile Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets | £5M | Seed | Biotech | United Kingdom | Investors | |
| E EfferonCompany profile Develops hemoadsorption therapeutic devices for sepsis and septic shock treatment Develops hemoadsorption therapeutic devices for sepsis and septic shock treatment | €2.5M | Seed | Biotech | Germany | Investors Undisclosed | |
| ER Engine RoomCompany profile Provides finance and accounting support to venture-backed life science companies Provides finance and accounting support to venture-backed life science companies | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors | |
| Q QuberTechCompany profile Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech | £3.4M | Seed | Biotech | United Kingdom | Investors | |
| BB Blank BioCompany profile Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology | $7.2M | Seed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.